Gewurz H, Mold C, Siegel J, Fiedel B
Adv Intern Med. 1982;27:345-72.
Since its discovery approximately fifty years ago, CRP has been recognized as the prototype acute phase reactant. Now appreciated as a trace serum protein that elevates markedly in concentration in association with inflammation and tissue necrosis, CRP also has been found deposited at sites of cell injury. Together with its long appreciated ability to initiate precipitation, agglutination, and capsular swelling reactions, these considerations early led to the surmise that CRP may play a role in the host adaptive response. Studies of its binding specificities have indicated that CRP has reactivity with (a) phosphocholine and phosphate esters, and hence with lipids widely distributed in mammalian and microbial cells; and (b) with multiple widely distributed polycations, including those derived from leukocyte granules. Interaction with either of these ligands has been shown to alter CRP in such a way that it can bring about activation of the complement system with generation of all the known C-dependent reactivities, including component consumption, adherence, phagocytosis, and cytolysis. Similarly, modified CRP has been shown to react with the FcR or a closely related receptor of monocytes and lead to phagocytosis, to react with certain FcR-bearing lymphocytes, and to activate the platelet. Thus, CRP shares with immunoglobulins the ability to initiate multiple effector functions that have been associated with the inflammatory response, as well as to bring about primary recognition reactions. Obviously CRP-ligand reactions would be favored during intervals of acute inflammation and tissue necrosis, when larger amounts of CRP are available. Therefore, in addition to serving as a diagnostic aid for the presence of inflammatory and necrotic processes, elevated levels of CRP may well provide an important component of the nonspecific host mechanisms, particularly in the early stages following inflammatory stimuli. Inquiries into the structure and function of CRP indicated an unexpected relationship of this molecule to an amyloid-related protein. The amyloid P component shows remarkable structural similarity to CRP and also exhibits calcium-dependent reactivity with widely distributed ligands; those appreciated to date have mainly involved polysaccharides derived from fungi and natural products. While the only relationship of SAP to an immune-related effector system found to date is reactivity with altered C3, it nonetheless seems plausible that SAP, which like CRP recognizes certain microbial and altered host molecules and has the potential of activating a host effector system at the recognition site. Further inquiry into the structure and functional relationships of these molecules, which are broadly distributed through the vertebrates, should help to reveal the role that CRP and other acute phase proteins have in the body economy and provide additional insights to the understanding of body defense mechanisms in inflammatory, repair, and defense processes generally.
自大约五十年前被发现以来,CRP一直被视为急性期反应物的原型。如今,它被认为是一种微量血清蛋白,其浓度会随着炎症和组织坏死而显著升高,同时也被发现沉积在细胞损伤部位。鉴于其长期以来被认可的引发沉淀、凝集和荚膜肿胀反应的能力,这些因素早期就引发了一种推测,即CRP可能在宿主适应性反应中发挥作用。对其结合特异性的研究表明,CRP与(a)磷酸胆碱和磷酸酯具有反应性,因此与广泛分布于哺乳动物和微生物细胞中的脂质具有反应性;以及(b)与多种广泛分布的聚阳离子具有反应性,包括那些源自白细胞颗粒的聚阳离子。已证明与这些配体中的任何一种相互作用都会以某种方式改变CRP,使其能够激活补体系统并产生所有已知的C依赖性反应,包括成分消耗、黏附、吞噬作用和细胞溶解。同样,已证明修饰后的CRP会与单核细胞的FcR或密切相关的受体发生反应并导致吞噬作用,与某些带有FcR的淋巴细胞发生反应,并激活血小板。因此,CRP与免疫球蛋白一样,具有引发与炎症反应相关的多种效应功能以及引发初级识别反应的能力。显然,在急性炎症和组织坏死期间,当有大量CRP可用时,CRP-配体反应会更有利。因此,除了作为炎症和坏死过程存在的诊断辅助指标外,CRP水平升高很可能是非特异性宿主机制的一个重要组成部分,特别是在炎症刺激后的早期阶段。对CRP结构和功能的研究表明,该分子与一种淀粉样相关蛋白存在意想不到的关系。淀粉样P成分与CRP表现出显著的结构相似性,并且也表现出与广泛分布的配体的钙依赖性反应性;迄今为止所认识到的主要涉及源自真菌和天然产物的多糖。虽然迄今为止发现的SAP与免疫相关效应系统的唯一关系是与改变的C3的反应性,但似乎合理的是,与CRP一样能识别某些微生物和改变的宿主分子并有可能在识别位点激活宿主效应系统的SAP。对这些广泛分布于脊椎动物中的分子的结构和功能关系进行进一步研究,应该有助于揭示CRP和其他急性期蛋白在机体代谢中的作用,并为更全面地理解炎症、修复和防御过程中的机体防御机制提供更多见解。